Atlas Trials

Jemincare

34 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Jemincare

RecordFirmDate
Trial of JYB1904 Injection in Adolescent Participants (NCT07513857)Jemincare2026-05-17
Drug-Drug Interactions of JMKX003142 in Healthy Participants (NCT07565441)Jemincare2026-05-11
Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis (NCT07459452)Jemincare2026-04-01
A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults (NCT07470177)Jemincare2026-03-27
Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers (NCT07463053)Jemincare2026-03-18
Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria. (NCT07402213)Jemincare2026-03-09
Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC (NCT07242274)Jemincare2025-12-31
Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects (NCT07181265)Jemincare2025-10-30
A Study of JMKX005425 in Patients With MSI-H/dMMR Advanced Solid Tumors (NCT07208136)Jemincare2025-10-22
A Dose-finding Study of JMKX003142 in Treatment of Renal Edema (NCT06670534)Jemincare2025-10-17
A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema (NCT06949020)Jemincare2025-07-09
A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation (NCT06946927)Jemincare2025-06-06
Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD) (NCT06800651)Jemincare2025-03-13
Study of JMKX003948 Ophthalmic Suspension in Healthy Participants (NCT06832657)Jemincare2025-02-01
Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia (NCT06664125)Jemincare2024-12-30
A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion (NCT06740019)Jemincare2024-12-28
Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects (NCT06658964)Jemincare2024-11-05
Trial of JMKX003801 in Healthy Participants (NCT06549309)Jemincare2024-08-17
Trial of JYB1904 in Chronic Spontaneous Urticaria. (NCT06509334)Jemincare2024-08-04
To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects (NCT06473948)Jemincare2024-07-10
Trial of JYB1904 in Patients With Allergic Asthma (NCT06438757)Jemincare2024-06-19
Study of JMKX003142 Injection in Chinese Healthy Subjects (NCT06344533)Jemincare2024-04-10
Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects (NCT06348290)Jemincare2024-04-01
Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain (NCT06221241)Jemincare2024-03-25
A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma (NCT06321250)Jemincare2024-03-14
JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus (NCT05967520)Jemincare2023-09-21
A DDI Study of JMKX000623 and Metformin Hydrochloride (NCT06066060)Jemincare2023-09-17
JYB1907 in Subjects With Advanced Solid Tumors (NCT05821595)Jemincare2023-07-31
Phase 1 Clinical Study of JMKX003142 Tablets (NCT06079541)Jemincare2023-07-06
Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China (NCT06880848)Jemincare2023-06-21
A Phase I Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion (NCT05923515)Jemincare2023-05-22
Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy Subjects (NCT05907382)Jemincare2023-05-09
Study of JYB1904 (an Anti-immunoglobulin E Antibody) in Healthy Chinese Subjects (NCT05449535)Jemincare2022-05-07
Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis (NCT04349683)Jemincare2020-04-30

Track Jemincare automatically

Every clearance here is in the API, with alerts when new ones post.